(NYSE: AVNT) Avient's forecast annual revenue growth rate of 2.38% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.66%.
Avient's revenue in 2025 is $3,246,100,000.On average, 12 Wall Street analysts forecast AVNT's revenue for 2026 to be $310,492,262,548, with the lowest AVNT revenue forecast at $293,095,173,228, and the highest AVNT revenue forecast at $324,318,370,376.
In 2027, AVNT is forecast to generate $320,930,516,140 in revenue, with the lowest revenue forecast at $301,885,281,516 and the highest revenue forecast at $339,517,932,624.